Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: Cardiovascular and metabolic consequences

Seminars in Nephrology

Volumn 26, Issue 1, 2006, Pages 20-23

  Perna, Alessandra F ^a   Capasso, Rosanna ^a   Acanfora, Filomena ^a   Satta, Ersilia ^a   Lombardi, Cinzia ^a   Ingrosso, Diego ^a   Violetti, Eleonora ^a   Romano, Maria Maddalena ^a   De Santo, Natale G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Chronic renal failure; Folate receptors; Homocysteine; Hypomethylation; Uremia; Uremic toxins

Indexed keywords

ISOASPARTIC ACID; MEMBRANE PROTEIN;

CARDIOVASCULAR DISEASE; CELL METABOLISM; CHRONIC KIDNEY FAILURE; ERYTHROCYTE; GENE EXPRESSION; HUMAN; HYPERHOMOCYSTEINEMIA; METABOLIC DISORDER; METHYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; STRUCTURE ACTIVITY RELATION; TOXICITY; UREMIA;

EID: 30444434397     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2005.06.005     Document Type: Article

References (12)

1. F. Mallamaci, C. Zoccali, G. Tripepi on behalf of the CREED InvestigatorsHyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients Kidney Int 61 2002 609 614
2. K. Kalantar-Zadeh, G. Block, M.H. Humphreys A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients J Am Soc Nephrol 15 2004 442 453
3. E.M. Wrone, J.M. Hornberger, J.L. Zehnder Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease J Am Soc Nephrol 15 2004 420 426
4. A.C. Antony, Y. Tang, R.A. Khan Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions J Clin Invest 113 2004 285 301
5. K. Robinson, A. Gupta, V. Dennis Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations Circulation 94 1996 2743 2748
6. A.F. Perna, D. Ingrosso, P. Galletti Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure Evidence for high levels of the natural inhibitor S-adenosylhomocysteine. J Clin Invest 91 1993 2497 2503
7. A.F. Perna, D. Ingrosso, N.G. De Santo Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia Kidney Int 47 1995 247 253
8. D. Ingrosso, A. Cimmino, A.F. Perna Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uremia Lancet 361 2003 1693 1699
9. A.F. Perna, A. D'Aniello, J.D. Lowenson D-aspartate content of erythrocyte membrane proteins is decreased in uremia Implications for the repair of damaged proteins J Am Soc Nephrol 8 1997 95 104
10. S. Clarke Aging as was between chemical and biochemical processes Protein methylation and the recognition of age-damaged proteins for repair Ageing Res Rev 2 2003 263 285
11. A.F. Perna, D. Ingrosso, E. Satta Plasma protein aspartyl damage is increased in hemodialysis patients Studies on causes and consequences J Am Soc Nephrol 15 2004 2747 2754
12. H. Jakubowski Biosynthesis and reactions of homocysteine thiolactonein R. Carmel D. Jacobsen 2001 Cambridge University Press Cambridge, UK 21 31